MRI Core for Alzheimer’s Disease imaging data
Official title: MRI Core
Funded at Northern California Institute/res/edu · NIH-11395215 · Data updated 2026-11-12
A large imaging core project to collect and share MRI data from people with Alzheimer’s disease and related conditions to support better understanding and future treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northern California Institute/res/edu NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 30, 2004 |
| Project end | July 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $2,230,362 |
| NIH project number | 5U19AG024904-19 |
| Project ID | NIH-11395215 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals with Alzheimer’s disease, mild cognitive impairment, or related dementias who would undergo MRI as part of their standard or research assessments.
✕Less likely to help
Participants not directly involved in data collection or with contraindications to MRI may not receive personal benefit.
What this research studies
If you or a loved one has Alzheimer’s disease or related dementia, this program helps create standardized brain MRI data and tools that researchers use to design trials and study aging. The project will generate and curate MRI scans using widely used, clinically approved sequences, and will provide processed data and summaries to researchers worldwide. This could accelerate discovery of imaging markers and improve how we track disease progression and response to therapies. Participation typically involves MRI procedures and consent for data sharing with researchers.
Why it matters
Potential benefit: Could lead to better biomarkers and more efficient, targeted Alzheimer’s trials in the future.
How similar studies have gone: Past MRI cores and large imaging consortia have successfully advanced imaging biomarkers and trial design in Alzheimer’s disease.
Where this research is happening
-
Northern California Institute/res/edu
San Francisco, United States Active
Researchers
- Principal investigator: Jack, Clifford R. — Northern California Institute/res/edu
- Study coordinator: Jack, Clifford R.
Related research
Other NIH-funded projects on the same topics.
-
Eyes and autoimmune signals after Ebola: long-term eye issues and biology
This grant looks at why some Ebola survivors develop long-lasting eye problems and what immune or biological clues might predict them.
-
Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4)
A large study to validate biomarkers that help test Alzheimer's treatments and improve how we design trials for people at risk or with Alzheimer’s disease.
-
Alzheimer's Biomarker Initiative to Improve Trials and Care
A large study to validate biomarkers for Alzheimer’s disease and improve how future trials recruit and monitor people at risk.
-
Alzheimer's Disease Neuroimaging Initiative: Advancing biomarkers and recruitment for dementia research
A large NIH-supported project is continuing to collect and share brain imaging, biofluid, genetic, and clinical data to validate biomarkers for Alzheimer’s trials and to recruit people at higher risk of dementia.
-
Alzheimer’s Disease Neuroimaging Initiative: improving biomarkers and trials
A large NIH program is advancing how we measure Alzheimer’s disease and recruit people at risk so future treatments can be tested more effectively.
-
CiLostAzol for preventing recurrent stroke in Africa
This grant tests whether adding cilostazol to standard therapy can reduce recurrent stroke in stroke survivors in sub-Saharan Africa.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.